No Cover Image

Journal article 838 views

Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK

Andrew Moore, Ceri Phillips, Elke Hunsche, James Pellissier, Simone Crespi

PharmacoEconomics, Volume: 22, Issue: 10, Pages: 643 - 660

Swansea University Author: Ceri Phillips

Full text not available from this repository: check for access using links below.

Published in: PharmacoEconomics
ISSN: 1170-7690
Published: 2004
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa1252
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2013-07-23T11:46:42Z
last_indexed 2018-02-09T04:28:17Z
id cronfa1252
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2011-10-01T00:00:00.0000000</datestamp><bib-version>v2</bib-version><id>1252</id><entry>2011-10-01</entry><title>Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK</title><swanseaauthors><author><sid>932c7a406ab4b6e4a881d422ca03c289</sid><firstname>Ceri</firstname><surname>Phillips</surname><name>Ceri Phillips</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2011-10-01</date><deptcode>FGMHL</deptcode><abstract></abstract><type>Journal Article</type><journal>PharmacoEconomics</journal><volume>22</volume><journalNumber>10</journalNumber><paginationStart>643</paginationStart><paginationEnd>660</paginationEnd><publisher/><placeOfPublication/><issnPrint>1170-7690</issnPrint><issnElectronic/><keywords/><publishedDay>31</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2004</publishedYear><publishedDate>2004-12-31</publishedDate><doi>10.2165/00019053-200422100-00003</doi><url/><notes>In the light of the removal of a number of Cox-II inhibitors this paper is very important in the context of pain management programmes and the development of a new class of Cox-II inhibitors from a European perspective.</notes><college>COLLEGE NANME</college><department>Medicine, Health and Life Science - Faculty</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>FGMHL</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2011-10-01T00:00:00.0000000</lastEdited><Created>2011-10-01T00:00:00.0000000</Created><path><level id="1">College of Human and Health Sciences</level><level id="2">Executive Team</level></path><authors><author><firstname>Andrew</firstname><surname>Moore</surname><order>1</order></author><author><firstname>Ceri</firstname><surname>Phillips</surname><order>2</order></author><author><firstname>Elke</firstname><surname>Hunsche</surname><order>3</order></author><author><firstname>James</firstname><surname>Pellissier</surname><order>4</order></author><author><firstname>Simone</firstname><surname>Crespi</surname><order>5</order></author></authors><documents/><OutputDurs/></rfc1807>
spelling 2011-10-01T00:00:00.0000000 v2 1252 2011-10-01 Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK 932c7a406ab4b6e4a881d422ca03c289 Ceri Phillips Ceri Phillips true false 2011-10-01 FGMHL Journal Article PharmacoEconomics 22 10 643 660 1170-7690 31 12 2004 2004-12-31 10.2165/00019053-200422100-00003 In the light of the removal of a number of Cox-II inhibitors this paper is very important in the context of pain management programmes and the development of a new class of Cox-II inhibitors from a European perspective. COLLEGE NANME Medicine, Health and Life Science - Faculty COLLEGE CODE FGMHL Swansea University 2011-10-01T00:00:00.0000000 2011-10-01T00:00:00.0000000 College of Human and Health Sciences Executive Team Andrew Moore 1 Ceri Phillips 2 Elke Hunsche 3 James Pellissier 4 Simone Crespi 5
title Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK
spellingShingle Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK
Ceri Phillips
title_short Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK
title_full Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK
title_fullStr Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK
title_full_unstemmed Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK
title_sort Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK
author_id_str_mv 932c7a406ab4b6e4a881d422ca03c289
author_id_fullname_str_mv 932c7a406ab4b6e4a881d422ca03c289_***_Ceri Phillips
author Ceri Phillips
author2 Andrew Moore
Ceri Phillips
Elke Hunsche
James Pellissier
Simone Crespi
format Journal article
container_title PharmacoEconomics
container_volume 22
container_issue 10
container_start_page 643
publishDate 2004
institution Swansea University
issn 1170-7690
doi_str_mv 10.2165/00019053-200422100-00003
college_str College of Human and Health Sciences
hierarchytype
hierarchy_top_id collegeofhumanandhealthsciences
hierarchy_top_title College of Human and Health Sciences
hierarchy_parent_id collegeofhumanandhealthsciences
hierarchy_parent_title College of Human and Health Sciences
department_str Executive Team{{{_:::_}}}College of Human and Health Sciences{{{_:::_}}}Executive Team
document_store_str 0
active_str 0
published_date 2004-12-31T03:06:44Z
_version_ 1756777523875676160
score 10.927107